Lindsay E. James

676 total citations
10 papers, 487 citations indexed

About

Lindsay E. James is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lindsay E. James has authored 10 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Lindsay E. James's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Lindsay E. James is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Lindsay E. James collaborates with scholars based in United Kingdom. Lindsay E. James's co-authors include Allan Hackshaw, Stephen Spiro, Robin Rudd, Hani Gabra, Siow Ming Lee, Gordon Rustin, Jonathan A. Ledermann, Gordon C. Jayson, Mark Jitlal and Colin Trask and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Lindsay E. James

10 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindsay E. James United Kingdom 7 335 200 172 171 121 10 487
A. Badzio Poland 15 323 1.0× 169 0.8× 132 0.8× 169 1.0× 82 0.7× 47 620
Michael Coutts United Kingdom 12 126 0.4× 105 0.5× 69 0.4× 140 0.8× 122 1.0× 20 379
J Genollá Spain 11 198 0.6× 134 0.7× 105 0.6× 82 0.5× 36 0.3× 37 447
Michèle Natale Germany 8 293 0.9× 50 0.3× 86 0.5× 256 1.5× 25 0.2× 25 415
Cláudia Casanova Italy 9 273 0.8× 50 0.3× 100 0.6× 267 1.6× 58 0.5× 24 421
Yu Yu Andreeva Russia 9 127 0.4× 94 0.5× 118 0.7× 57 0.3× 59 0.5× 70 351
Anna Maria Mosconi Italy 13 364 1.1× 27 0.1× 140 0.8× 90 0.5× 136 1.1× 39 558
Hitomi Sumiyoshi Okuma Japan 11 209 0.6× 66 0.3× 65 0.4× 109 0.6× 11 0.1× 53 336
T. Giannakakis Greece 13 367 1.1× 60 0.3× 79 0.5× 90 0.5× 25 0.2× 24 457
Lindsey E. Minion United States 8 170 0.5× 34 0.2× 142 0.8× 50 0.3× 152 1.3× 15 438

Countries citing papers authored by Lindsay E. James

Since Specialization
Citations

This map shows the geographic impact of Lindsay E. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay E. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay E. James more than expected).

Fields of papers citing papers by Lindsay E. James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsay E. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay E. James. The network helps show where Lindsay E. James may publish in the future.

Co-authorship network of co-authors of Lindsay E. James

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsay E. James. A scholar is included among the top collaborators of Lindsay E. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsay E. James. Lindsay E. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Seckl, Michael J., Christian H. Ottensmeier, Michael Cullen, et al.. (2013). A multicenter phase III randomized double-blind placebo controlled trial of pravastatin added to first-line standard chemotherapy in patients with small cell lung cancer (SCLC).. Journal of Clinical Oncology. 31(15_suppl). 7595–7595. 2 indexed citations
2.
McNeish, Iain A., Jonathan A. Ledermann, Lindsay E. James, et al.. (2013). A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC).. Journal of Clinical Oncology. 31(15_suppl). 5514–5514. 5 indexed citations
3.
Ledermann, Jonathan A., Allan Hackshaw, Gordon C. Jayson, et al.. (2011). Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. Journal of Clinical Oncology. 29(28). 3798–3804. 164 indexed citations
4.
Ledermann, Jonathan A., Hani Gabra, Gordon C. Jayson, et al.. (2010). Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer. Clinical Cancer Research. 16(19). 4899–4905. 39 indexed citations
5.
Lee, Siow Ming, Penella J. Woll, Robin Rudd, et al.. (2009). Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. JNCI Journal of the National Cancer Institute. 101(15). 1049–1057. 95 indexed citations
6.
Lee, Siow Ming, Penella J. Woll, Lindsay E. James, et al.. (2007). PRS-04: A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). Journal of Thoracic Oncology. 2(8). S306–S307. 14 indexed citations
7.
8.
Spiro, Stephen, Lindsay E. James, Robin Rudd, et al.. (2006). Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis. Journal of Clinical Oncology. 24(24). 3823–3830. 124 indexed citations
9.
James, Lindsay E., Stephen Spiro, Robin Rudd, et al.. (2003). O-69 A randomized study of timing of thoracic irradiation in small cell lung cancer (SCLC) — study 8. Lung Cancer. 41. S23–S23. 17 indexed citations
10.
James, Lindsay E. & Siow Ming Lee. (2003). P-363 A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). Lung Cancer. 41. S183–S183. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Badzio Breakdown of academic impact, for papers by Michael Coutts Breakdown of academic impact, for papers by J Genollá Breakdown of academic impact, for papers by Michèle Natale Breakdown of academic impact, for papers by Cláudia Casanova Breakdown of academic impact, for papers by Yu Yu Andreeva Breakdown of academic impact, for papers by Anna Maria Mosconi Breakdown of academic impact, for papers by Hitomi Sumiyoshi Okuma Breakdown of academic impact, for papers by T. Giannakakis Breakdown of academic impact, for papers by Lindsey E. Minion
Rankless by CCL
2026